Search
-
Navigating the Health Plan Partnership Labyrinth
By understanding health plan imperatives, digital health companies can strategically position themselves for mutually beneficial collaborations and unlock significant commercial opportunities.
-
Reuters Pharma USA
Join Ipsos experts who will host a detailed Workshop designed for pharma marketers.
-
February 2024 Reuters/Ipsos Core Political
Findings of the February 2024 Reuters/Ipsos Core Political
-
Majority of Americans oppose Alabama Supreme Court ruling around IVF
New Axios/Ipsos poll shows fewer than half are familiar with the ruling, but those who are aware stand in strong opposition
-
Truth, Beauty, and Justice: AI in 2024
Revisit our recorded discussion to hear more about the three necessary domains for evaluating AI - Truth (accuracy), Beauty (fertility), and Justice (fairness) - and the implications of each from the perspectives of our guest panelists.
-
MDVIP/Ipsos poll shows Americans are struggling with the healthcare system
Despite this, many Americans have a positive view of their personal doctors
-
It's a major global election year, and populism is on the ballot
Below are five charts on where the world stands on populism and where things could head in 2024
-
ESG: A hidden driver for brand success in healthcare
Read how life sciences companies can go beyond the organizational level and apply their ESG strategy to individual brands, and how doing so with authenticity can serve as an additional factor driving brand success.
-
ASCO Annual Meeting 2024
Are you planning to be at ASCO 2024? Don’t mistake conference buzz for oncologist engagement!
-
Understanding Patients with Metastatic Breast Cancer – A Preference for Oral Treatments
Research conducted by Ipsos in collaboration with Living Beyond Breast Cancer and funded by Eli Lilly and Company explores the time commitment and treatment preferences among women living with ER+, HER2- metastatic breast cancer